| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8316776 | Clinica Chimica Acta | 2008 | 7 Pages |
Abstract
False positive acetaminophen tests may result when enzymatic-colorimetric assays are used, most commonly with bilirubin concentrations >Â 10Â mg/dl, leading to potential clinical errors in this setting. Bilirubin (or possibly other substances in acute liver failure sera) appears to affect the reliable measurement of acetaminophen, particularly with enzymatic-colorimetric assays.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Julie Polson, Frank H. Jr., Paul Orsulak, Dwain Fuller, Natalie G. Murray, Jonathan M. Koff, Adil I. Khan, Jody A. Balko, Linda S. Hynan, William M. Lee, the Acute Liver Failure Study Group the Acute Liver Failure Study Group,